About
Antoine Boulanger joined Apollo Health Ventures as a Partner in 2025. He was previously a Principal at Forbion, where he sourced and managed biotech and therapeutics investments, and he began his career in life sciences equity research and venture capital, including due diligence work at BDC's Healthcare Venture Fund in Canada. He holds a Ph.D. in Molecular Medicine from Laval University, with published research in muscle physiology and neuromuscular disease.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Apollo Health VenturesPartnercurrent2025 — present
- ForbionPrincipal2024 — 2025Naarden, North Holland, Netherlands
- ForbionSenior Associate2022 — 2024
- ForbionAssociate2020 — 2022Naarden, Netherlands
- ForbionAnalyst2019 — 2020Naarden, Netherlands
- BDCHealthcare Venture Fund - Venture Capital2017Région de Montréal, Canada
Skills & more
Molecular Medicine27Entrepreneurship27Skeletal muscle physiology21Physiology18Pharmaceutical Industry17Strategy14Mergers & Acquisitions11Finance11Venture Capital11Start-ups16
From Antoine's professional profile.
Investments
Led
Versanis Bio
Board seats
Armgo PharmaAzafarosCalluna PharmaDyne TherapeuticsInversago PharmaMestag TherapeuticsRectify Pharma
Per the firm's website.
Colleagues at Apollo Health Ventures
Alexandra Bause
Co-Founder and Venture Partner at Apollo Health Ventures
Anela Vukoja
COO at Apollo Health Ventures
Anne Marije van Harten
Investment Director at Apollo Health Ventures
Christopher R. Shepard
Venture Partner at Apollo Health Ventures
Dr. Alexandra Bause
Co-Founder & Venture Partner at Apollo Health Ventures
Dr. Gerd Hummel
Venture Partner at Apollo Health Ventures
Dr. Jeanne Bolger
Advisor at Apollo Health Ventures
Dr. Jens Eckstein
Advisor at Apollo Health Ventures
Frequently asked questions
- Who is Antoine Boulanger?
- Antoine Boulanger joined Apollo Health Ventures as a Partner in 2025. He was previously a Principal at Forbion, where he sourced and managed biotech and therapeutics investments, and he began his career in life sciences equity research and venture capital, including due diligence work at BDC's Healthcare Venture Fund in Canada. He holds a Ph.D. in Molecular Medicine from Laval University, with published research in muscle physiology and neuromuscular disease.
- Where does Antoine Boulanger work?
- Antoine Boulanger is Partner at Apollo Health Ventures.
- What does Antoine Boulanger invest in?
- Antoine Boulanger invests in Biotech.
- What boards does Antoine Boulanger sit on?
- Antoine Boulanger holds tracked board seats at Armgo Pharma, Azafaros, Calluna Pharma, Dyne Therapeutics, Inversago Pharma, Mestag Therapeutics, Rectify Pharma.
- What companies has Antoine Boulanger invested in?
- Investments tracked here include Versanis Bio.
- Where did Antoine Boulanger go to school?
- Antoine Boulanger studied at Université Laval (Doctor of Philosophy (Ph.D.), Molecular Medicine); The Wharton School (Business Foundations Specialization Certificate); Université Laval (Master of Science (M.Sc.), Molecular Medicine).
- Does Antoine Boulanger lead rounds?
- Yes — Antoine Boulanger has led 1 tracked investment.
Same school
Also attended Université Laval36
Laura WeigertSenior Associate at Marlin Equity PartnersLeah BaePrincipal at Higher Ground LabsDylan Lawrence MissonnierInvestment Director at CapagroWenceslas MoussaHead of Risk & Compliance at HeadlineChris ArsenaultFounder and Partner at Inovia CapitalSophie GuptaPrincipal at Yaletown Partners
+ 30 more
Also attended The Wharton School1,557
Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic
+ 1,551 more
Shared employers
Also worked at Forbion23
Christina TakkeManaging Partner at V-Bio VenturesMathias FalcenbergVenture Partner at V-Bio VenturesIvan BurkovJunior Partner at InkefAnne Marije van HartenInvestment Director at Apollo Health VenturesRobbert van de GriendtHead of Investment Relations at BioGeneration VenturesDirk KerstenManaging Partner at Forbion
+ 17 more















.jpg)














